• 503Pharma
  • Posts
  • 503Pharma Weekly Compounding Pharmacy Roundup

503Pharma Weekly Compounding Pharmacy Roundup

Your trusted source for compounding pharmacy education, news and insights.

News and Regulatory Updates

  1. Eli Lilly lawsuit against a Texas compounder moves forward—partially
    A federal judge dismissed some claims but allowed others to proceed in Lilly’s case over alleged mass compounding of GLP-1 drugs. https://news.bloomberglaw.com/litigation/judge-trims-lilly-suit-over-mass-produced-copycat-obesity-drugs

  2. Congress reintroduces SAFE Compounding Drugs Act
    Representatives Nikki Budzinski (D-IL), Rudy Yakym (R-IN), and Jake Auchincloss (D-MA) reintroduced the SAFE Compounding Drugs Act aimed at tightening oversight of large-scale compounding while preserving access through hospitals and 503B facilities. https://carson.house.gov/media/press-releases/yakym-carson-introduce-bill-protect-patients-unsafe-compounded-drugs

  3. ASHP Midyear highlights persistent compliance gaps
    At ASHP Midyear, speakers emphasized that many compounding failures stem from execution—training, documentation, and workflow—not lack of intent. https://www.drugtopics.com/view/successful-pharmacy-compounding-relies-on-keeping-the-focus-on-patients-ashp-midyear-2025

Featured Article

You’re Invited: 503Pharma, Invite-Only Community is Now Live!

We're excited to announce the launch of the 503Pharma Members Area — a private online community built for compounding pharmacy professionals

  • Community Discussion Forum — Connect with peers, ask questions, and share insights on compounding, compliance, business operations, and industry news

  • Professional Profiles — Build your profile with your credentials, specialty areas, and organization to connect with the right people

  • Direct Messaging — Have private conversations with other members in the community

  • Formula Request Network — Submit and discover compounding formula requests from pharmacies across the network

CompoundLearn is LIVE!

CompoundLearn was built to simplify USP <795>, <797>, and <800> training—and keep you inspection-ready.

  • Full access to 25 training modules and 77 lessons covering critical USP 795, 797, and 800 topics

  • Role-based assignments — assign and track the right training curriculum to designated persons/pharmacists-in-charge, compounders, and trainers

  • Quizzes that prove that your team knows the material

  • Downloadable certificates for your training records

👉 https://app.compoundlearn.com/

✉️ That’s your 503Pharma weekly digest. Our mission is to keep compounding professionals informed, prepared, and ahead of the curve.